$ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Healthcare
Sector
Biotechnology
Industry
Lawrence Otto Klein
CEO
28
Employees
$112.66
Current Price
$34.82M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 4 | $782,882.06 | 7,000 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 15 | $7,490,863.17 | 69,000 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 15 | $7,490,863.17 | 69,000 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 27 | $309,427,466.03 | 3,644,409 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 42 | $313,461,349.25 | 3,701,859 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Dambkowski Carl Director | Sale | 22,417 | $70.13 | $1,572,200.60 | View Details |
| Jun 12, 2026 | Dambkowski Carl Director | Sale | 12,583 | $70.11 | $882,181.55 | View Details |
40 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 41โ42 of 42 transactions
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: